Pharmacology Update: Emergency and Controller Medications for Treatment of Asthma

Anil Nanda1, Anne F Russell2, Theresa A Bingemann3

  • 1Allergist/Immunologist, Associate Clinical Professor of Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, Asthma and Allergy Center, Lewisville and Flower Mound, TX.

Insights

Childhood asthma is a common chronic condition impacting millions of children. Effective asthma management involves fast-acting symptom relief and controller medications like inhaled corticosteroids and newer biologics.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Pharmacology

Background:

  • Asthma is the most prevalent noncommunicable chronic childhood disease in the U.S., affecting over 5 million children.
  • It is a primary cause of school absenteeism among children.
  • Current asthma treatments are categorized into fast-acting symptom relievers and slower-acting controller medications.

Purpose of the Study:

  • To provide an overview of current asthma treatments for children.
  • To highlight the different classes of medications used for asthma management.
  • To introduce novel biologic therapies for asthma control.

Main Methods:

  • Review of existing literature on asthma pharmacotherapy.
  • Categorization of asthma medications based on mechanism of action and usage.
  • Discussion of delivery devices and adjuncts for medication efficacy.

Main Results:

  • Fast-acting medications like Albuterol are crucial for symptom relief.
  • Controller therapies, primarily inhaled corticosteroids, are foundational for asthma management.
  • Other controller options include long-acting beta agonists, antimuscarinics, antileukotrienes, and emerging biologics.

Conclusions:

  • A multi-faceted approach combining fast-acting and controller medications is essential for effective asthma care.
  • Optimizing medication delivery through devices like spacers can enhance treatment outcomes.
  • Biologics represent a significant advancement in managing severe or persistent asthma.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
672
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
730
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
863
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K